Convenzione Ministries – Human Technopole: National Facilities approved
The Consiglio di Sorveglianza of the Human Technopole Foundation has approved the implementation of five National Facilities, intended as infrastructural facilities with a high technological impact, available to the national research community.
As prescribed by the Convenzione stipulated pursuant to Law 160/2019, the approval follows a two-stage public consultation process: the first stage involved representatives of universities, research hospitals, public research organisations, industry, regions, social partners and third sector bodies conducting or funding research in the life sciences. The results collected during the first phase were then shared with the Italian scientific community to collect their comments and opinions.
The National Facilities identified are as follows:
- National Facility for Genomics
- National Facility for Genome Engineering
- National Facility for Structural Biology
- National Facility for Light Imaging
- National Facility for Data Handling & Analysis
The preparation of the call for the expression of interest is currently underway to collect applications from highly qualified scientists, with no affiliation or existing assignments with the HT Foundation, universities, Italian research hospitals and public research bodies, interested in joining the Standing Independent Evaluation Committee (Commissione Indipendente di Valutazione Permanente – CIVP) in charge of evaluating the requests to access to the National Facilities.
Share:
You could also like:
-
Colorectal Cancer: ML Enhances Cetuximab Response Predictions
An international collaborative study led by Human Technopole, Candiolo Cancer Institute IRCCS in Turin, the University of Turin, and the Wellcome Sanger Institute in Cambridge (UK) has identified new factors associated with therapeutic response in colorectal cancer. The research has led to the development of a machine-learning model capable of accurately predicting the effects of cetuximab, a drug in clinical use, on different colorectal tumour subtypes. Funded by the AIRC Foundation, the study paves the way to identifying molecular features that could serve as biomarkers for predicting treatment response in patients with this type of cancer.
-
Human Technopole Foundation’s Supplier List online
The Human Technopole Foundation’s Supplier Register is now online.
-
HT Director Zerial Awarded Mercurio Prize for Excellence in Research
The Human Technopole Director, Marino Zerial, has been awarded the 2024 Mercurio Prize in the “Research and Development” category, in recognition of the excellence of his research in the field of cell biology. Zerial, renowned for his studies on the mechanisms of endocytosis and cellular transport, has made significant contributions to the understanding of cellular dynamics, with potential therapeutic applications for diseases such as liver conditions.
-
A new model system for cortical development in vitro
Researchers from Human Technopole, the Institute of Molecular Biotechnology and Bicocca University established a method for developing brain assembloids that allows reproducing salient aspects of the antero-posterior polarity of the human cerebral cortex in vitro and opens new possibilities for disease modelling. The study is published in Nature Methods.
-
The National Facility for Genomics with Clelia Peano
Meet Clelia Peano, Head of the National Facility for Genomics. The Facility offers cutting-edge services to develop robust experimental and analytical workflows to explore different genomic research areas, including DNA and RNA analysis, chromatin structure, and epigenetic mechanisms regulating transcription. The goal is to enhance genomic research in all its aspects, benefiting the entire Italian scientific community.